Iron Deficiency in Pulmonary Hypertension.
Study Goal
The researchers aimed to review the prevalence, implications, and therapeutic potential of addressing iron deficiency in patients with pulmonary hypertension (PH).
Results Summary
Iron deficiency in PH patients is linked to worsened clinical outcomes, and while iron supplementation shows variable improvements in exercise capacity and hemodynamics, the benefits are not universal. The review highlights the need for personalized treatment approaches and further research.
Population
Patients with pulmonary hypertension (PH) and iron deficiency.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
iron supplementation | increase | exercise capacity | patients with PH | - | improvements | #1 |
iron supplementation | increase | hemodynamic parameters | patients with PH | - | improvements | #2 |
iron deficiency | decrease | exercise capacity | patients with PH | - | associated with worsened clinical outcomes | #3 |
iron deficiency | decrease | oxygen transport and utilization | patients with PH | - | associated with worsened clinical outcomes | #4 |
iron deficiency | decrease | right ventricular function | patients with PH | - | associated with worsened clinical outcomes | #5 |
Pulmonary hypertension (PH) is a complex cardiovascular condition that is characterized by elevated pulmonary arterial pressure, which leads to significant morbidity and mortality. Among the various factors that influence the pathophysiology and progression of PH, iron deficiency has become a critical, yet often overlooked, element. In this review, the prevalence, implications, and therapeutic potential of addressing iron deficiency in patients with PH are elucidated.Iron deficiency, which is prevalent in a significant proportion of patients with PH, has been associated with worsened clinical outcomes, including diminished exercise capacity, impaired oxygen transport and utilization, and compromised right ventricular function. The pathophysiological linkages between iron deficiency and PH are multifaceted and involve alterations in oxygen sensing, endothelial function, and metabolic disturbances.In this review, the evidence from recent clinical trials and studies that assess the impact of iron supplementation, both oral and intravenous, on PH outcomes is critically analyzed. Although some studies suggest improvements in exercise capacity and hemodynamic parameters following iron repletion, the responses appear variable and are not universally beneficial. This review highlights the complexities of iron metabolism in PH and the challenges in effectively diagnosing and treating iron deficiency in this patient population.Furthermore, the potential mechanisms through which iron supplementation might influence pulmonary vascular and right ventricular function, emphasizing the need for personalized treatment approaches are discussed. In this review, the importance of recognizing iron deficiency in the management of patients with PH is highlighted, and further research is warranted to establish comprehensive, evidence-based guidelines for iron supplementation in this unique patient cohort. The ultimate goal of this review is to improve clinical outcomes and quality of life for patients suffering from this debilitating condition.